SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000891092-07-001189
Filing Date
2007-03-30
Accepted
2007-03-30 16:47:43
Documents
13
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K e26589_10k.htm 10-K 1067265
2 STOCK OPTION AWARD AGREEMENT e26589ex10_11.txt EX-10.11 24339
3 STOCK OPTION AWARD AGREEMENT e26589ex10_12.txt EX-10.12 24350
4 STOCK OPTION AWARD AGREEMENT e26589ex10_13.txt EX-10.13 24016
5 FIRST AMEND TO THE STOCK OPTION AWARD AGRMENT e26589ex10_14.txt EX-10.14 3502
6 FIRST AMEND TO THE STOCK OPTION AWARD AGRMENT e26589ex10_15.txt EX-10.15 3482
7 FIRST AMEND TO THE STOCK OPTION AWARD AGRMENT e26589ex10_16.txt EX-10.16 3442
8 EMPLOYMENT AGREEMENT e26589ex10_17.txt EX-10.17 36097
9 PROTALIX BIOTHERAPEUTICS, INC. e26589ex21_1.txt EX-21.1 486
10 CERTIFICATION e26589ex31_1.txt EX-31.1 3612
11 CERTIFICATION e26589ex31_2.txt EX-31.2 3601
12 CERTIFICATION e26589ex32_1.txt EX-32.1 1404
13 CERTIFICATION e26589ex32_2.txt EX-32.2 1466
  Complete submission text file 0000891092-07-001189.txt   1198794
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 07733476
SIC: 2836 Biological Products, (No Diagnostic Substances)